Tyrosine kinase fusion genes in chronic myeloproliferative diseases. (Q34718214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Tyrosine kinase fusion genes in chronic myeloproliferative diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Reiter A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1207-1212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

publication type of scholarly work

10 November 2019

review article

1 reference

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Cytogenetics of chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Haematological classification of the chronic myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

BCR rearrangement-negative chronic myelogenous leukemia revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Identification of four new translocations involving FGFR1 in myeloid disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Receptor signaling: when dimerization is not enough

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

The ins and outs of fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Cytogenetic peculiarities in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Chronic myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98/HOXA9 fusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Ph-negative chronic myelocytic leukemia with a complex translocation involving chromosomes 7 and 11

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Roots of clinical resistance to STI-571 cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402556

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12094244%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 November 2019

1043654498

0 references

1 reference